Katie Nega , ARNP, GNP-BC

Nuclear Medicine

Teaching Associate
Nuclear Medicine, Theranostics

Expertise

Prostate Cancer, Thyroid Cancer, and Neuroendocrine Tumors.

Biography

I am a nurse practitioner who sees patients at FHCC in South Lake Union. 

I have an extensive background in geriatrics and worked in the Genitourinary Oncology clinic at UWMC managing care for prostate cancer patients for many years. I love helping cancer patients effectively manage their cancer related symptoms and enjoy collaborating with other departments within FHCC to make sure our patients have the best experience possible. As a nurse practitioner, I enjoy the opportunity to empower and teach patients and their families through education.

When I am not working, I enjoy yoga, listening to live music, fine dining and soaking up as much Vitamin D as I can with my husband, two daughters and dog.

Education

2006-2008  Masters of Science in Nursing– University of Illinois at Chicago

1997-2001  Bachelor of Science in Nursing- University of Washington

Recent Publications (via Semantic Scholar)

Reply by Authors.
M. Schweizer, L. True, R. Gulati, et al. - Published 2023 - JOURNAL OF UROLOGY

Pathological Effects of Apalutamide in Lower-risk Prostate Cancer: Results From a Phase II Clinical Trial
M. Schweizer, L. True, R. Gulati, et al. - Published 2023 - JOURNAL OF UROLOGY

Transcriptomic discriminators of response to apalutamide in patients with prostate cancer (PC) on active surveillance (AS).
M. Schweizer, R. Gulati, Yang Liu, et al. - Published 2022 - JOURNAL OF CLINICAL ONCOLOGY

Bipolar androgen therapy plus olaparib in men with metastatic castration-resistant prostate cancer
M. Schweizer, R. Gulati, T. Yezefski, et al. - Published 2022 - PROSTATE CANCER AND PROSTATIC DISEASES

Targeting backdoor androgen synthesis through AKR1C3 inhibition: A presurgical hormonal ablative neoadjuvant trial in high‐risk localized prostate cancer
Laura S. Graham, L. True, R. Gulati, et al. - Published 2021 - THE PROSTATE

592P Bipolar androgen therapy (BAT) plus olaparib in men with metastatic castration-resistant prostate cancer (mCRPC)
M. Schweizer, R. Gulati, T. Yezefski, et al. - Published 2021 - ANNALS OF ONCOLOGY